StockData
QuidelOrtho Corp logo

QuidelOrtho Corp (QDEL) stock

QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3063% below fair value
$9.57−0.30 (-3.04%)

Close on Nov 18, 2026Market cap $656.27MP/E –Yield –

QuidelOrtho price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

QuidelOrtho's price to book ratio was 0.5× on Nov 11, 2026, against 0.9× a year earlier. Over the last 5 years it ranged from 0.4× to 4.4×, with a median of 0.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.5×−0.5
2025Dec 31, 20251.0×+0.0
2024Dec 31, 20240.9×−0.1
2023Dec 29, 20231.0×−0.2
2022Dec 30, 20221.2×−3.2
2021Dec 31, 20214.4×–

More QuidelOrtho figures

See a number that looks wrong?